Circulating level of CTRP1 in patients with nonalcoholic fatty liver disease (NAFLD): is it through insulin resistance?
Nonalcoholic fatty liver disease (NAFLD) is considered as one of the most common liver diseases. It is robustly linked to obesity and insulin resistance and is regarded as hepatic manifestation of metabolic syndrome (MetS). Adipokines are involved in the pathophysiology of liver diseases. The aim of...
Main Authors: | Parisa Shabani, H Naeimi Khaledi, Maani Beigy, Solaleh Emamgholipour, Eskandar Parvaz, Hossein Poustchi, Mahmood Doosti |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0118650 |
Similar Items
-
The Circulating CTRP13 in Type 2 Diabetes and Non-Alcoholic Fatty Liver Patients.
by: Mehrnoosh Shanaki, et al.
Published: (2016-01-01) -
The circulating levels of CTRP1 and CTRP5 are associated with obesity indices and carotid intima-media thickness (cIMT) value in patients with type 2 diabetes: a preliminary study
by: Ziba Majidi, et al.
Published: (2021-01-01) -
Lower circulating levels of CTRP12 and CTRP13 in polycystic ovarian syndrome: Irrespective of obesity.
by: Mehrnoosh Shanaki, et al.
Published: (2018-01-01) -
Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD)
by: Judith Wylie-Rosett, et al.
Published: (2013-10-01) -
Association of circulating CTRP9 with soluble adhesion molecules and inflammatory markers in patients with type 2 diabetes mellitus and coronary artery disease.
by: Nariman Moradi, et al.
Published: (2018-01-01)